Foundation Medicine today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing.

test offerings to include MET IHC testing using the VENTANA® MET (SP44) RxDx assay, now available as an add-on to comprehensive genomic profiling (CGP) test orders for patients with non-squamous ...

The global immunohistochemistry (IHC) market is experiencing steady growth, with a compound annual growth rate (CAGR) of ...

The Pathology Department of Ongole Government General Hospital (GGH) and Medical College on Monday has launched advanced ...

NeoGenomics has commercially launched the c-MET Companion Diagnostic (CDx) for use in non-small cell lung cancer (NSCLC).

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – As traditional research institutions ...

Emergency Medical Transportation Market share is projected to be valued at USD 10.8 billion in 2025 and reach USD 19.9 billion by 2034, growing at a CAGR of 7.6% according to a new report by The ...

Petratherm is set to commence bulk sample testwork at its Rosewood prospect, part of the Muckanippie Project in South Australia. This follows a drilling program that identified a ...

Petratherm (ASX:PTR) plans for bulk sample testwork at Rosewood prospect within the Mackanippie Project, after identifying a ...

Effect of low-dose rapamycin on the therapeutic response to radio-immunotherapy in hepatocellular carcinoma. Multi-omics analysis of PD-1 inhibitor combination in neoadjuvant treatment of pMMR/MSS ...

MG Windsor Pro was launched as a long-range iteration of the Windsor EV, equipped with a bigger battery pack and a more ...